[Video Presentation] Architecting AI: Rethinking Medical Imaging & Defining the Strategy | January 10, 2019 | Health Exec | Around the webCardiovascular Business Boston Scientific enters renal denervation market with acquisition worth up to $540MBoston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. Radiology Business Shift toward imaging outside the hospital could save billionsHarvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.Cardiovascular Business FDA announces catheter recall for Johnson & Johnson PFA system due to stroke riskThe recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.
